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Spatial regulation of exocytosis relies on the exocyst, a hetero-octameric protein
complex that tethers vesicles to fusion sites at the plasma membrane. Nevertheless, our
understanding of mechanisms regulating exocyst assembly/disassembly, localization,
and function are incomplete. Here, we have exploited a panel of anti-Sec6 monoclonal
antibodies (mAbs) to probe possible configurational changes accompanying transitions
in exocyst function in epithelial MDCK cells. Sec6 is quantitatively associated with Sec8 in
high molecular weight complexes, as shown by gel filtration and co-immunoprecipitation
studies. We mapped epitopes recognized by more than 20 distinct mAbs to one
of six Sec6 segments. Surprisingly, mAbs that bound epitopes in each segment
labeled distinct subcellular structures. In general, antibodies to epitopes in N-terminal
domains labeled Sec6 in either cytosolic or nuclear pools, whereas those that
bound epitopes in C-terminal domains labeled membrane-associated Sec6. In this
latter group, we identified antibodies that labeled distinct Sec6 populations at the
apical junctional complex, desmosomes, endoplasmic reticulum and vimentin-type
intermediate filaments. That each antibody was specific was verified by both Sec6
RNAi and competition with fusion proteins containing each domain. Comparison of
non-polarized and polarized cells revealed that many Sec6 epitopes either redistribute or
become concealed during epithelial polarization. Transitions in exocyst configurations
may be regulated in part by the actions of Ral GTPases, because the exposure of
Sec6 C-terminal domain epitopes at the plasma membrane is significantly reduced
upon RalA RNAi. To determine whether spatio-temporal changes in epitope accessibility
was correlated with differential stability of interactions between Sec6 and other exocyst
subunits, we quantified relative amounts of each subunit that co-immunoprecipitated
with Sec6 when antibodies to N-terminal or C-terminal epitopes were used. Antibodies
to Sec6NT co-precipitated substantially more Sec5, -10, -15, Exo70 and -84 than did
those to Sec6CT. In contrast, antibodies to Sec6CT co-precipitatedmore Sec3 and Sec8
than did those to Sec6NT. These results are consistent with a model in which exocyst
activation during periods of rapid membrane expansion is accompanied by molecular
rearrangements within the holocomplex or association with accessory proteins, which
expose the Sec6 C-terminal domain when the complex is membrane-bound and conceal
it when the complex is cytoplasmic.
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INTRODUCTION
Exocysts are multifunctional protein scaffolds that mediate
vesicle tethering during exocytosis (Luo et al., 2014), but also
function in many other membrane trafficking pathways during
endocytic recycling and transcytosis (Jafar-Nejad et al., 2005;
Oztan et al., 2007), cytokinesis (Fielding et al., 2005; Gromley
et al., 2005; Cascone et al., 2008), ciliogenesis (Zuo et al.,
2009; Das and Guo, 2011), and ciliary shedding (Overgaard
et al., 2009), cell motility (Rosse et al., 2006; Zuo et al., 2006;
Spiczka and Yeaman, 2008), autophagy (Bodemann et al., 2011;
Simicek et al., 2013), membrane nanotube formation (Hase
et al., 2009), invadopodia formation (Sakurai-Yageta et al.,
2008; Liu et al., 2009), phagocytosis (Mohammadi and Isberg,
2013), and bacterial invasion into host cells (Nichols and
Casanova, 2010). Not all activities that have been attributed
to exocyst complexes involve the tethering of membranes,
however. Additional functions for exocyst components have been
described in tumor cell survival (Chien et al., 2006), innate
immunity signaling (Ishikawa et al., 2009; Simicek et al., 2013),
and DNA repair (Torres et al., 2015).
In order to coordinate exocyst activities in such a diversity
of events, cells must exert precise spatio-temporal regulation
over exocyst recruitment to different cellular compartments and
association with additional factors that execute specific functions
there. A growing list of exocyst-binding proteins is emerging
(Sivaram et al., 2005; France et al., 2006; Medkova et al., 2006;
Goehring et al., 2007; Jin et al., 2011; Parrini et al., 2011; Morgera
et al., 2012; Dubuke et al., 2015), and for many of those that have
been examined, their localization and function is dependent on
recruitment to exocyst complexes at those sites (Fielding et al.,
2005; Gromley et al., 2005). Most “accessory proteins” do not
bind the exocyst consitutively, but do so in a manner that is
regulated by either phosphorylation (Chen et al., 2011; Stalder
and Novick, 2016) or, more commonly, small GTPases (Chien
et al., 2006; Rittmeyer et al., 2008; Sakurai-Yageta et al., 2008;
Spiczka and Yeaman, 2008; Lalli, 2009; Bodemann et al., 2011;
Pathak et al., 2012; Das et al., 2014).
We hypothesize that exocysts are allosterically regulated
scaffolds that expose or conceal binding sites for pathway-
specific factors at different times and places within cells. By
electron microscopy, purified endogenous exocyst complexes
from Saccharomyces cerevisiae resemble a collection of long
rods, which consist of tightly packed helical bundles that may
represent individual subunits of the complex (Heider et al., 2016).
This structure is consistent with images generated by quick-
freeze/deep-etch electron microscopy of glutaraldehyde-fixed
exocyst complexes purified from rat brain extracts (Hsu et al.,
1996). However, in the same study non-fixed exocyst complexes
appeared as flowers with four to six “petals” (Hsu et al., 1996).
This has prompted speculation that exocyst complexes may
exist in different conformational states (e.g., “open” vs. “closed”;
Munson and Novick, 2006). If exocyst activities are regulated
through either conformational changes within the holocomplex
or spatio-temporal control of accessory protein binding to the
holocomplex, then one prediction is that different epitopes on
the complex would be exposed when one exocyst is at one
site engaged in one activity, but concealed on another exocyst
performing a different function at a different site.
Previous studies support this prediction. For example,
distinct cohorts of monoclonal antibodies were reported to
label different populations of exocyst complexes associated with
plasma membrane and trans-Golgi network of normal rat kidney
cells (Yeaman et al., 2001). In addition, polyclonal antibodies
raised against either the N- or C-terminus of Sec3 labeled
plasma membranes of epithelial MDCK cells, but only N-
terminal specific antibodies labeled an additional population of
Sec3 associated with a perinuclear compartment (Andersen and
Yeaman, 2010). Depending on the specific antibody used, the
degree of cellular polarization and the manner in which cells
were permeabilized and fixed, Sec8 has been variously localized
to different plasma membrane domains (Bryant et al., 2010),
intercellular junctions (Grindstaff et al., 1998; Yeaman et al.,
2004; Andersen and Yeaman, 2010), centrosomes (Rogers et al.,
2004), and endosomal populations (Folsch et al., 2003; Prigent
et al., 2003; Oztan et al., 2007) in MDCK cells. Finally, in a
number of studies individual exocyst subunits have been reported
to have distinct localization patterns (Vik-Mo et al., 2003; Beronja
et al., 2005; Mehta et al., 2005; Bryant et al., 2010; Bodemann
et al., 2011). Whether these results reflect functionally distinct
exocyst sub-complexes or dynamic intermediates of holocomplex
assembly and disassembly is not clear, and is difficult to reconcile
with recent findings that exocyst exists predominantly as a stable
hetero-octamer, at least in budding yeast (Heider et al., 2016).
Progress toward a thorough understanding of this essential
complex and its diverse functions will require careful analysis of
its myriad associations and how exocyst assembly, disassembly
and activity is regulated. Although results of immunolocalization
studies of this complex in mammalian cells must be interpreted
cautiously, we hypothesize that careful analysis with a panel of
monoclonal antibodies can reveal important details about exocyst
functions and regulation during its involvement in a host of
cellular activities.
MATERIAL AND METHODS
Antibodies
Mouse monoclonal antibodies (mAbs) against Sec6 and Sec8
have either been described previously (Hsu et al., 1996; Kee
et al., 1997; Yeaman et al., 2001) or were produced at the
same time as previously described mAbs were. mAbs against
Sec5, Exo70, and Exo84 were described previously (Vega and
Hsu, 2001; Wang and Hsu, 2003; Spiczka and Yeaman, 2008),
as was anti-CDC10 rabbit polyclonal antibody (Hsu et al.,
1998). Rabbit polyclonal antibodies against Sec3, Sec5, Sec10,
Sec15, Exo70, and Exo84 have also been described previously
(Yeaman, 2003; Andersen and Yeaman, 2010). Rabbit polyclonal
antibodies against Nop2 (NBP1-92192) and vimentin (NBP1-
31327) were from Novus Biologica (Littleton, CO). Rabbit
anti-desmoplakin-1/2 (ab14418) was from Abcam (Cambridge,
MA), rabbit anti-pericentrin (PRB-432C) was from BioLegend
(San Diego, CA), rabbit anti-β-tubulin (mAb 9F3) was from
Cell Signaling Technology (Danvers, MA) and rabbit anti-
calnexin (ADI-SPA-865) was from Enzo Life Sciences, Inc.
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(Farmingdale, NY). Fluorescein isothiocyanate (FITC)-goat anti-
mouse, Texas Red (TR)-donkey anti-rabbit and Alexa594 goat
anti-rabbit immunoglobulin (Ig)G were purchased from Jackson
ImmunoResearch Laboratories (West Grove, PA). Horseradish
peroxidase-conjugated goat anti-mouse and goat anti-rabbit
antibodies were purchased from Promega (Madison, WI).
Cell Culture
Madin-Darby Canine Kidney (MDCK) strain II cells were
maintained in low-glucose Dulbecco’s modified Eagle’s
medium (LG-DMEM) with 1.8mM Ca2+ containing 1 g/l
sodium bicarbonate and supplemented with 10% fetal bovine
serum (FBS; Cell Generation, Fort Collins, CO), penicillin,
streptomycin, and gentamicin (PSG) and grown at 37◦C with
5% CO2. For disruption of microtubules or actin, cells were
incubated in medium containing either 20 µg/ml nocodazole
(Sigma, St. Louis, MO) for 2 h (Reaves and Banting, 1992), or
2 µM cytochalasin D for 60min (Stevenson and Begg, 1994).
shSec6 cells were generated by stable integration of short
hairpin RNAs (shRNAs) targeting canine Sec6 (sense: 5′-
GCTGCTCAGATAAGTGAAGAT-3′). shRNA was delivered via
transduction with a recombinant lentiviral vector that was
pseudotyped with vesicular stomatitis virus G protein. Cells
were selected and maintained in medium containing 5 µg/ml
puromycin. Negative controls were generated by transducing
MDCK II cells with lentiviral vectors encoding a non-targeting
shRNA (sense: 5′-CCAGACCTTCAAGGAATCCAT-3′) and
selecting them in puromycin. Sec6 rescue cells were generated
by introducing 3 wobble-base point mutations into the first three
codons of the target Sec6 hairpin sequence of canine Sec6 cDNA.
This cDNA was ligated into pQCXIN and delivered into shSec6
cells via retroviral transduction. Transfected cells were selected
using 400 µg/ml G418 and assayed by immunofluorescence and
immunoblotting for hairpin resistant (hr) Sec6. shCtrl, shRalA
and shRalB MDCK II cells were described previously (Hazelett
et al., 2011).
Three-dimensional cysts of MDCK cells were generated as
described (Bryant et al., 2010). Prior to seeding cells, a thin layer
of growth factor-reduced Matrigel (BD Biosciences, Bedford,
MA) was spread into 8-well Lab-Tek Chambered Coverglass
slides and placed at 37◦C for 10 min. Cells were trypsinized and
diluted in ice-cold media to a concentration of 4 × 104 cells/ml.
Matrigel was diluted in ice-cold media to 4%. Matrigel solutions
and cell suspensions were mixed 1:1 yielding 2 × 104 cells/ml
in a 2% Matrigel solution. Solutions were then added to wells of
chambered coverglass slides and placed at 37◦C for 4 days.
Epitope Mapping
Sequences from a cDNA encoding rat Sec6 were subcloned into
the pGEX-KG vector to express as GST-fusion proteins in E. coli.
Initially, four Sec6 fragments were generated, corresponding to
amino acid residues 2–125 (Sec6.1 = NT1), 126–376 (Sec6.2
= NT2), 377–597 (Sec6.3), and 586–755 (Sec6.4). Subsequently,
fragments of the C-terminal half were redesigned based on
structural characterization of yeast Sec6 (Songer and Munson,
2009) and expressed as CT1 (residues 377–487), CT2 (residues
488–625), and CT3 (residues 626–755). GST-fusion proteins were
purified from bacterial lysates and serial three-fold dilutions were
applied to Immobilon PVDF membrane (Millipore) and blocked
with Blotto (5% nonfat dry milk, 0.5% normal goat serum, and
0.1% sodium azide in TBS) overnight at 4◦C. Dot blots were
incubated with primary antibodies overnight at 4◦C, and then
washed 5 times with TST (TBS containing 0.1% Tween-20), 10
min each. Finally, blots were incubated with HRP-labeled goat
anti-mouse IgG for 45min at room temperature and then washed
as above. After 2 final washes with TBS, blots were incubated with
SuperSignal West Pico Chemiluminescent Substrate (Thermo
Scientific) and visualized with a ChemiDoc-It
TM
Imaging System
and quantified with Visionworks Software (UVP; Upland, CA).
Segments labeled CT2a and CT2b in Figure 1 were defined
by comparing results obtained with the original Sec6.3/6.4
fragments and the redesigned Sec6 CT1/CT2/CT3 fragments.
Because mAbs 2B12, 3F3, 8E6, and 8G7 bound both the Sec6.3
and CT2 fragments, whilst mAb 11A2 bound the Sec6.4 and
CT2 fragments, it was deduced that these antibody groups bound
FIGURE 1 | Epitope mapping analysis of Sec6 monoclonal antibodies. Antibodies produced by 24 different hybridomas were tested for binding specificity to
seven recombinant Sec6 fragments, defining 6 distinct protein segments. Amino acid residues marking the boundaries of these segments in rat Sec6 are shown
above each. See text for details.
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FIGURE 2 | Antibodies to different Sec6 subdomains label distinct subcellular structures. (A) Immunofluorescent labeling of MDCK cells with antibodies to
Sec6 NT1 (mAb 13F10), NT2 (mAb 16G4), CT1 (mAb 10C3), CT2a (mAb 3F3), CT2b (mAb 11A2), or CT3 (mAb 8A5) subdomains (“α-Sec6”) or hybridoma
(Continued)
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FIGURE 2 | Continued
supernatants that were pre-incubated with recombinant Sec6 fragments containing epitopes recognized by those antibodies (“depleted”). Additional mAbs to Sec6
NT1 (mAb 8F9), NT2 (mAb 22F5), and CT1 (mAb 4C8) subdomains produced immunolocalization patterns that were indistinguishable from those of other mAbs that
bound within the same subdomain. Cells were fixed with either 4% paraformaldehyde (NT1 and CT1) or 100% methanol (NT2, CT2a, CT2b, and CT3). For NT1 and
NT2 labeling, cells were extracted with 1% Triton X-100 prior to fixation, and in top and bottom panels DNA was labeled with DAPI (blue). Bars = 10 µm.
(B) Immunoblotting of Sec6 in detergent lysates of MDCK cells. Proteins (3, 1, 0.3, or 0.1 µg) were separated by SDS-PAGE and electrophoretically transferred to
Immobilon P membranes. Membranes were probed with pooled antibodies to indicated Sec6 subdomains (“α-Sec6”), or with hybridoma supernatants that were
pre-incubated with recombinant Sec6 fragments containing epitopes recognized by those antibodies (“Depleted”). An immunoblot probed for β-tubulin is shown as a
loading control. Protein standards indicated are β-galactosidase (116 kDa), phosphorylase b (97 kDa), bovine serum albumin (66 kDa), egg albumin (45 kDa), and
carbonic anhydrase (29 kDa).
FIGURE 3 | Other exocyst subunits co-localize with Sec6 at sites labeled with subdomain-specific mAbs. Immunofluorescent labeling of MDCK cells with
mouse monoclonal antibodies to Sec8 [mAb 10C2, (A), green] or Sec6 [either mAb 3F3, (B) top row, green or mAb 22F5, (B) bottom row, green] and rabbit
polyclonal antibodies to Sec15 [Rb. 96, (B) top row, red] or Sec3 [Rb. 92, (B) bottom row, red]. Cells were fixed with either 100% methanol [(A,B), top row] or were
extracted with 1% Triton X-100 prior to fixation with 4% paraformaldehyde [(B), bottom row]. DNA was labeled with DAPI (blue). Bars = 10 µm.
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different epitopes within the CT2 domain, herein labeled CT2a
and CT2b.
Immunofluorescent Labeling
Samples were fixed on ice with either 100% methanol (MeOH)
or 4% paraformaldehyde (PFA) for 20min, either prior to or
following extraction with CSK buffer (1% Triton X-100, 10mM
Pipes, pH 6.8, 50mM NaCl, 300 mM sucrose, 3mM MgCl2)
supplemented with protease inhibitors (1mM pefabloc and
10 µg/ml each of aprotinin, antipain, leupeptin, and pepstatin A)
for 10min. PFA-fixed samples were then quenched with Ringer’s
saline (154 mM NaCl, 1.8mM Ca2+, 7.2mM KCl, and 10mM
FIGURE 4 | Characterization of novel Sec6 localizations. MDCK cells were fixed as described for Figure 2A and co-labeled with antibodies to Sec6 NT1 (mAb
13F10), NT2 (mAb 16G4), CT2a (mAb 3F3), or CT2b (mAb 11A2) (green) and antibodies to indicated proteins (red). In panels showing merged images, DNA was
labeled with DAPI (blue). Bars = 5 µm.
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HEPES, pH 7.4) containing 50mM NH4Cl. After samples were
blocked with 0.2% fish skin gelatin in Ringer’s saline (blocking
buffer) for 1 h, primary antibodies were diluted in blocking
buffer and applied for 1 h at room temperature or overnight at
4◦C with gentle rocking. After 5 washes with blocking buffer,
secondary antibodies and DAPI were applied for 30 min at
room temperature. Samples were washed 5 times with blocking
buffer, and filters and coverslips were mounted onto slides using
Elvanol-PPD. For processing MDCK cysts, all buffers were at
room temperature and secondary antibodies were applied for 1 h.
Images were obtained using either a Zeiss 510 scanning confocal
microscope (Thornwood, NY; 63X objective) equipped with a
krypton/argon laser (FITC excitation using 488 nm laser line and
Texas Red excitation using 543 laser line), or with a Leica DMI
6000B microscope equipped with a BD CARV II spinning disk
confocal imager. Stacks of confocal images were collected from
several different fields using a 63X objective and a Photometrics
QuantEM 512SC EM-CCD high-speed camera.
For studies examining immunofluorescence intensity at
the plasma membrane, serial optical sections were merged
and antibody labeling intensities at lateral plasma membranes
were quantified by tracing the outlines of ∼50 cells from 5
representative fields and determiningmean pixel intensities using
the wand tool with ImageJ software. For each sample, values
were normalized by dividing the pixel intensity of Sec6 labeling
by that of Sec3 labeling. One-way ANOVA with Tukey’s post-
test statistical analyses were performed for each cell type, and
differences were considered significant where p < 0.05.
Immunoprecipitation
MDCK cells were washed 3 times with Ringer’s saline on
ice, and lysed in RIPA buffer (50 mM Tris-HCl pH 7.5, 1
% NP-40, 0.5% sodium deoxycholate, 150 mM NaCl, and
1 mM EDTA) containing protease inhibitors. Cell lysates
were collected in 1.5 ml Eppendorf tubes and incubated
on ice for 20 min at 4◦C. Extracts were precleared with 5
µl of nonimmune serum and 50 µl Staphylococcus aureus
cells (Pansorbin; Calbiochem Novabiochem, La Jolla, CA)
for 1 h at 4◦C. For Sec8 immunoprecipitation, mAbs 2E12,
5C3 and 10C2 were covalently cross-linked to Protein A
Sepharose beads (Pharmacia LKB Nuclear, Gaithersburg,
MD) with dimethyl pimelimidate (DMP), and 20 µl of
immunoadsorbant was used per immunoprecipitation. For
Sec6 NT or CT immunoprecipitations, combinations of
either mABs that bind epitopes in NT1 or NT2 domains
or those that bind epitopes in CT1, CT2, or CT3 domains
were bound to Protein G Sepharose. Immunoadsorbants
were incubated with pre-cleared cell extracts for 2 h at 4◦C,
then washed under stringent conditions and prepared for
SDS-PAGE as described previously (Andersen and Yeaman,
2010).
Superose 6 FPLC Analysis
Confluent monolayers of MDCK cells were extracted for 10 min
at 4◦C in Tris-saline buffer containing 0.5% (v/v) NP-40 and
protease inhibitors. Cell lysates were centrifuged at 15,000 × g
for 10min. The supernatant fraction was centrifuged at 100,000
× g for 30min and passed through a 0.22 µm syringe filter
(Millipore). Two hundred microliters of this lysate was applied
to a Superose 6 HR 10/30 column and fractionated as described
previously (Stewart and Nelson, 1997). Fractions 6–28 were
separated by SDS-PAGE and proteins were electrophoretically
transferred to Immobilon P membranes for immunoblotting
with specific antibodies.
FIGURE 5 | Immunologically distinct pools of Sec6 are localized at AJC and desmosomes. MDCK cells were fixed and labeled with indicated antibodies to
Sec6 (green) and the desmosome component, desmoplakin (red). Note that mAb 8A5 detects a pool of Sec6 that co-localizes with desmoplakin. In contrast, mAb
9H5 detects a pool of Sec6 that does not co-localize with desmosome proteins. Bar = 10 µm.
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Gel Electrophoresis and Immunoblotting
Protein samples were incubated in SDS-PAGE sample buffer for
10 min at 65◦C before separation on 10% SDS polyacrylamide
gels. Proteins were electrophoretically transferred onto
Immobilon PVDF membrane (Millipore) and blocked with
Blotto (5% nonfat dry milk, 0.5% normal goat serum, and 0.1%
FIGURE 6 | Characterication of filamentous Sec6 mAb 11A2 labeling.
(A) MDCK cells were fixed with either 100% methanol (top and bottom rows)
or 4% paraformaldehyde (middle row) and co-labeled with antibodies to Sec6
CT2b (mAb 11A2) and either β-tubulin or Cdc10 or with phalloidin. Bars = 10
µm. (B) MDCK cells were treated with either nocodazole or cytochalasin D, as
described in Material and Methods. Cells were fixed with 100% methanol and
co-labeled with antibodies to Sec6 CT2b (mAb 11A2) and β-tubulin. Panels on
the right show cells that were fixed with 4% paraformaldehyde and labeled
with phalloidin to demonstrate appearance of the actin cytoskeleton following
treatment with drugs. Bars = 10 µm.
sodium azide in TBS) overnight at 4◦C. Immunoblots were
incubated with primary antibodies overnight at 4◦C, and then
washed 5 times with TST (TBS containing 0.1% Tween-20),
10 min each. Finally, immunoblots were incubated with HRP-
labeled goat anti-mouse or goat anti-rabbit antibodies for 45 min
at room temperature. Immunoblots were washed as above, then
twice with TBS. Immunoblots were incubated with SuperSignal
West Pico Chemiluminescent Substrate (Thermo Scientific) and
visualized with a ChemiDoc-It
TM
Imaging System and quantified
with Visionworks Software (UVP; Upland, CA).
RESULTS
Epitope Mapping Defines Distribution of
Antibody Binding Sites on Sec6
In the course of characterizing the mammalian exocyst complex,
more than 30 monoclonal antibodies were generated against a
His-tagged rSec6 fusion protein that specifically immunoblotted
a single 86 kDa protein in rat brain homogenate (Hsu et al.,
1996; Kee et al., 1997) and cell lines (Grindstaff et al., 1998;
Yeaman et al., 2001). To conduct an informed analysis of Sec6
immunolocalization in epithelial cells, we first mapped epitopes
recognized by 24 of these mAbs to one of seven recombinant Sec6
fragments, which defined six unique segments of the protein.
Epitopes were distributed along the length of Sec6, and the nearly
all of antibodies (23) bound a single segment (Figure 1). Most
segments were detected by at least four mAbs, and the CT1
domain bound 11 mAbs. Intriguingly, one mAb (8A5) bound
epitopes in both the CT1 and CT3 domains. That this hybridoma
was monoclonal was confirmed by limiting dilution re-cloning
of cells. We conclude that the epitope bound by mAb 8A5 is
repeated in two segments of the Sec6 C-terminal domain.
Antibodies to Different Sec6 Sements
Label Distinct Subcellular Structures
When mAbs to different Sec6 segments were used to
immunolabel epithelial cells, many different subcellular
structures were revealed. Antibodies to the NT1 domain labeled
plasma membrane weakly, but strongly labeled Sec6 in the
cytosol and nucleus (Figure 2A). Sec8 mAb 10C2 labeled this
subunit in the nucleus in a distribution similar to that seen with
Sec6 NT1 antibodies (Figure 3). Sec6 NT1 epitopes were also
detected on centrosomes, similar to localizations previously
described for other exocyst subunits (Rogers et al., 2004; Zuo
et al., 2009; Andersen and Yeaman, 2010). However, Sec6 NT1
mAbs only bound centrosomes in cells undergoing mitosis
(Figures 2A, 4). Antibodies to epitopes in the NT2 domain also
labeled nuclei, but in contrast to NT1 epitopes, those in the
NT2 domain were concentrated in nucleoli (Figures 2A, 4). A
population of Sec3 co-localized with this nucleolar-associated
Sec6 pool (Figure 3). NT2-specific labeling became dispersed as
nucleoli dissassembled, and labeling was not detected in mitotic
cells (Figure 2A).
In contrast to N-terminal specific antibodies, mAbs that
bound epitopes within the C-terminal half of Sec6 mainly
labeledmembrane-associated complexes. Antibodies to Sec6 CT1
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include mAb 9H5, which has previously been shown to label
exocyst complexes associated with the apical junctional complex
(AJC), which includes tight junctions and adherens junctions
(Grindstaff et al., 1998; Yeaman et al., 2004; Figure 2A). This
pool of Sec6 has previously been shown to co-localize with Sec8
(Grindstaff et al., 1998; Yeaman et al., 2004) and Sec10 (Lipschutz
et al., 2000). Identical labeling patterns were observed with all of
the Sec6 mAbs binding epitopes in this fragment, with the single
exception of mAb 8A5. This antibody, which binds an epitope
repeated in the CT3 domain, labels desmosomes but not other
plasma membrane regions in non-polarized cells and polarized
cells grown on Transwell filters (Andersen and Yeaman, 2010;
Figures 2A, 5). As we reported previously, most exocyst subunits
can be found at desmosomes (Andersen and Yeaman, 2010; also
note membrane-associated pool of Sec3 in Figure 3).
Several of the mAbs that bound epitopes within the CT2a
domain did not label cells that had been fixed and permeabilized
under any conditions tested, but one of them (mAb 3F3)
strongly labeled internal membranes that were identified as
endoplasmic reticulum (ER) by co-labeling with a calnexin-
specific antibody (Figures 2A, 4). A similar labeling pattern was
observed with select antibodies against both Sec8 and Sec15,
supporting the conclusion that mAb 3F3 binds a population
of Sec6 in ER-associated exocyst complexes (Figure 3). Finally,
mAb 11A2, which binds a distinct epitope in the CT2 segment,
revealed a pool of Sec6 that was associated with a filamentous
cytoplasmic network (Figure 2A). This network was more
extensively labeled with antibodies to vimentin (Figure 4) than
it was with probes to other cytoskeletal networks, including
microtubules, actin filaments, Cdc10-positive septin filaments
(Figure 6A) and cytokeratins (not shown). Furthermore,
although some overlap was observed between 11A2 labeling and
microtubules and actin, filamentous Sec6 labeling was largely
refractory to pharmacological disruption of those cytoskeletal
structures with nocodazole or cytochalasin D, respectively
(Figure 6B).
To confirm that labeling with Sec6 mAbs was specific, two
strategies were employed. First, immunodepletion of hybridoma
supernatants with corresponding Sec6 fragments eliminated
specific immunodetection of Sec6 on immunoblots (Figure 2B)
and greatly reduced immunofluorescent staining associated
with different subcellular compartments (Figure 2A). This
confirmed that epitopes present in recombinant Sec6 fragments
bound antibodies that were responsible for immunolabeling
different organelles in cells. Cross-depletion of hybridoma
supernatants with Sec6 fragments that did not contain associated
epitopes did not diminish immunolabeling of cells (not shown).
Second, RNAi-mediated reduction of Sec6 expression by
>90% as verified by immunoblotting (Figure 7A) severely
reduced or completely eliminated all labeling patterns observed
FIGURE 7 | Sec6 knockdown eliminates, and re-expression restores labeling with all Sec6 mAbs in MDCK cells. (A) Sec6 knockdown and rescue. MDCK
cells were transduced with recombinant lentiviral vectors carrying either non-targeting shRNA (shCtrl) or shRNA targeting Sec6 (shSec6). Immunoblot analysis
confirmed that Sec6 protein expression was reduced in shSec6 cells by > 90% when normalized to loading control (β-tubulin). Rescue cell lines were established by
transduction of shSec6 cells with recombinant retroviral vectors carrying hairpin-resistant Sec6 cDNA. Immunoblot analysis confirmed that Sec6 protein expression
was restored to nearly identical levels as those in shCtrl cells. (B) Control (shCtrl), Sec6 knockdown (shSec6), and Sec6 rescue MDCK cells were processed for
immunofluorescent labeling with antibodies to indicated Sec6 subdomains, as described in Figure 2. Bar = 10 µm.
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(Figure 7B). This strongly supports the conclusion that Sec6
is the sole protein detected by all of the mAbs in cells. Finally,
expression of a hairpin-resistant Sec6 cDNA (Figure 7A)
restored immunolabeling of all of the observed compartments
FIGURE 8 | Sec6 epitopes redistribute during epithelial polarization. (A)
MDCK cells were cultured as sub-confluent colonies on collagen-coated glass
coverslips (non-polarized) or seeded in Matrigel and grown for 4 days
(polarized). Cultures were fixed in 100% methanol and labeled with indicated
anti-Sec6 mAbs (green). Polarized cultures were co-labeled with DAPI (blue).
Bar = 20 µm. (B) MDCK cells were seeded in Matrigel and grown for 4 days.
Cultures were either fixed in 100% methanol (left) or pre-extracted with 1%
Triton X-100 before methanol fixation (right), and labeled with indicated
antibodies (green) and DAPI (blue). Bar = 20 µm.
FIGURE 9 | RalA regulates plasma membrane exocyst configuration.
(A) Accessibility of Sec6 CT1 epitopes is reduced when RalA, but not RalB,
(Continued)
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FIGURE 9 | Continued
expression is suppressed. (Top) MDCK cells stably expressing a non-specific
short hairpin RNA (shCtrl), or a hairpin specific for either RalA (shRalA) or RalB
(shRalB), were fixed and labeled with a cocktail of mouse monoclonal
antibodies to Sec6 domain CT1 (mAbs 4C8, 9E9, 9H5, and 15C2). Cells were
co-labeled with rabbit polyclonal antisera against Sec3. Bound antibodies
were revealed by indirect immunofluorescence, following labeling with
FITC-anti-mouse and Texas Red-anti-rabbit antibodies. (Bottom) Antibody
labeling intensities at the plasma membrane were quantified as described in
Material and Methods. Note that Sec6CT labeling, which is primarily
concentrated at the lateral plasma membrane of control cells, is diminished
upon RalA, but not RalB reduction. This likely reflects differences in Sec6
conformation, rather than exocyst localization, because plasma membrane
Sec3 labeling is not changed following either knockdown. Bar = 20 micron,
**p < 0.05. (B) Levels of Sec3/6/8 complex are not altered following
suppression of either RalA or RalB expression. RIPA extracts of MDCK shCtrl,
shRalA, or shRalB cells were immunoprecipitated with anti-Sec8-bound
protein A sepharose. Equal fractions of input lysates and immunoprecipitates
were resolved by SDS-PAGE and immunoblotted with rabbit anti-Sec3, mouse
anti-Sec8(8F12) or mouse anti-Sec6(10D11) antibodies. An immunoblot
probed for β-tubulin is shown as a loading control.
FIGURE 10 | Sec6 is quantitatively associated with Sec8 in high
molecular weight complexes in MDCK cells. (A) All endogenous Sec6 is
bound to Sec8. MDCK RIPA extracts were immunoprecipitated 4 times with
anti-Sec8-bound protein A sepharose. Input lysate represents 10% of starting
material. Depleted lysate (“spent”) represents 50% of the final
post-immunoprecipitation supernatant. Samples were resolved by SDS-PAGE
and immunoblotted with anti-Sec8(8F12) and anti-Sec6(10D11) antibodies.
(B) Detergent extracts of polarized MDCK cells were fractionated by Superose
6 FPLC as described in Experimental Procedures. Fractions 9–27 were divided
into equal aliquots, separated by SDS-PAGE, and transferred to Immobilon P
membranes. Membranes were probed with anti-Sec8(8F12) and
anti-Sec6(10D11) antibodies. Elution peaks of globular protein standards with
known molecular weights were also determined: thyroglobulin, Mr = 669,000
(fraction 16); apoferritin, Mr = 443,000 (fraction 19); catalase, Mr = 232,000
(fraction 22); bovine serum albumin, Mr = 66,000 (fraction 25).
(Figure 7B), confirming not only that Sec6 is the protein
recognized by all of the mAbs on diverse structures, but also
that this diversity in labeling is not caused by alternatively
spliced Sec6 variants localizing to distinct subcellular
sites.
Sec6 Epitopes are Differentially Exposed or
Concealed During Epithelial Polarization
We next asked whether Sec6 epitopes were static, or whether
they became exposed or concealed at different subcellular sites
as cells underwent dynamic changes, as during morphogenesis
of a three-dimensional cyst. We therefore compared localization
profiles of epitopes bound by a subset of Sec6 mAbs in non-
polarized and 3-D cysts of MDCK cells. When antibodies to
epitopes in the C-terminal half of Sec6 were used, 2 patterns
were observed. First, epitopes in the CT2b and CT3 segments
appeared to redistribute during polarity development. In non-
polarized and Transwell-cultured (2-D) polarized cells, mAb 8A5
labeled Sec6 in a discontinuous, punctate pattern characteristic
of desmosomes, while mAb 11A2 labeled Sec6 on cytoskeletal
filaments (Andersen and Yeaman, 2010; Figure 8A). In contrast,
both antibodies revealed Sec6 in a uniform distribution along
the basolateral plasma membrane of fully polarized cells in 3-D
Matrigel cultures. In addition, mAb 11A2 detected Sec6 beneath
the lumenal apical plasmamembrane (Figure 8A).We note that a
population of Sec6 remains associated with cytoplasmic filaments
in 3-D cysts, but this pool is observed only when maximum
intensity projections of stacked optical sections through the
entire cyst are generated (not shown).
A second pattern was observed with antibodies to Sec6 CT1.
Epitopes within this protein segment became concealed as cells
developed polarity. For example, immunolabeling with mAb 9H5
was readily detected along lateral membranes of non-polarized
cells (Figure 8A) and this became restricted to the AJC as
cells acquired 2-D polarity when grown on Transwell filters
(Grindstaff et al., 1998; Yeaman et al., 2004). However, specific
Sec6 labeling was undetectable in fully polarized cells grown in
Matrigel (Figure 8A). Importantly, Sec6 is still present at AJC in
fully polarized cells, because its binding partner Sec8 was readily
detected there and an AJC-associated pool of Sec6 was revealed
when cells were gently extracted with non-ionic detergent prior
to fixation (Figure 8B). However, the CT1 domain becomes
masked at this site as cells undergo cystogenesis.
Sec6 Epitope Accessibility is Impacted by
RalA Activity
We hypothesize that Ral GTPases regulate exocyst activities
by facilitating association and/or dissociation of additional
proteins with the holocomplex scaffold. Ral-mediated assembly
or disassembly of exocyst super-complexes is expected to
involve structural changes that render Sec6 epitopes more or
less accessible to specific mAbs. To test this prediction, we
compared binding of antibodies to the Sec6 CT1 subdomain
in cells in which expression of either RalA or RalB had been
suppressed. This analysis revealed that exposure of Sec6 CT1
epitopes at the plasma membrane was significantly decreased
when expression of RalA, but not RalB, was reduced (Figure 9A).
Loss of peripheral Sec6 CT1 labeling in cells lacking RalA was
not due to inefficient recruitment of exocyst complexes to the
plasma membrane, because peripheral Sec3 labeling was similar
in control, shRalA and shRalB cells (Figure 9A). Furthermore,
expression levels of Sec3, Sec6 and Sec8, and their assembly into
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exocyst complexes was unaffected by suppressing either RalA or
RalB expression (Figure 9B). Collectively, these results support
the conclusion that exocyst conformation, rather than expression,
assembly or recruitment of the complex to the plasma membrane
is regulated by RalA activity.
Epitope Accessibility is Correlated with
Stability of Sec6 Interactions with Other
Exocyst Subunits
A possible explanation for why different Sec6 epitopes are
either exposed or concealed in cells is that Sec6 exists in
different complexes, and that spatially regulated associations
with other proteins either masks or reveals epitopes in different
parts of the cell or at different stages of polarity development.
Importantly, epithelial cells do not accumulate a significant pool
of free, monomeric Sec6. Quantitative immunoprecipiation of
Sec8 recovers nearly all of the Sec6 in cell extracts (Figure 10A).
This is consistent with a recent report that Sec6 and Sec8
form a stable subunit pair in budding yeast (Heider et al.,
2016). Gel filtration chromatography of MDCK cell lysates
shows that this Sec6/8 complex is always associated with
high molecular weight assemblies (Figure 10B). Therefore, the
diversity of immunolabeling patterns observed likely reflects
heterogeneity within multiple populations of large protein
assemblies containing Sec6.
FIGURE 11 | Antibodies to different Sec6 domains differentially
co-precipitate other exocyst subunits. Cocktails of antibodies specific for
epitopes in either the Sec6 N-terminus (8F9, 10D11, 13F10, 8A11, 1F5, 7C6,
16G4, and 22F) or C-terminus (9E9, 9H5, 10C3, 2B12, 3F3, 8E6, 11A2, and
8A5) were used to immunoprecipitate exocyst complexes from MDCK lysates.
Precipitates were resolved by SDS-PAGE and immunoblotted with antibodies
to either Sec6 or indicated exocyst subunits. Amounts of each subunit that
were recovered were normalized to amounts of Sec6 recovered in each
immunoprecipitate, and are expressed as a fraction of the total
immunoprecipitated by both Sec6 NT and CT antibody cocktails. Bars
represent means of three independent experiments, and error bars represent
standard deviations.
It is possible that Sec6 epitopes are differentially accessible
because exocyst holocomplexes undergo context-specific
conformational changes or shifts in inter-molecular interactions
that impact Sec6, such that individual subdomains are either
exposed or concealed. To test whether compartment-specific
exposure of different epitopes was correlated with differential
stability of interactions between Sec6 and other subunits, Sec6
was immunoprecipitated with cocktails of mAbs that bind
epitopes in either the N-terminal or C-terminal halves of the
protein, and the relative amounts of other exocyst subunits that
co-precipitated was measured (Figure 11). mAbs to Sec6NT
co-precipitated more Sec5, Sec10, Sec15, Exo70, and Exo84
than did those to Sec6CT. mAbs to Sec6CT, by contrast, co-
precipitated more Sec3 and Sec8 than did those to Sec6NT.
These results suggest that exocyst complexes may undergo
structural transitions that conceal Sec6NT but expose Sec6CT
when complexes are membrane-bound, and expose Sec6NT but
conceal Sec6CT when complexes are cytosolic or nuclear.
DISCUSSION
Previous studies of exocyst localization in mammalian epithelial
cells have revealed complexes at AJC (Grindstaff et al., 1998;
Yeaman et al., 2004) and desmosomes (Andersen and Yeaman,
2010) on basolateral plasma membranes, developing apical
plasma membranes (Bryant et al., 2010), trans-Golgi network
(Yeaman et al., 2001), recycling endosomes (Folsch et al., 2003;
Prigent et al., 2003; Oztan et al., 2007), primary cilia (Rogers
et al., 2004), and centrosomes (Rogers et al., 2004; Andersen
and Yeaman, 2010). Discrepancies in reported localizations may
reflect differences in fixation and permeabilization procedures,
specific antibodies used in the study, extent of cellular
polarization, growth conditions of cells, existence of exocyst sub-
complexes associated with different organelles and the possibility
that exocyst complexes may exist in different conformational
states. In this study, we have focused on a single exocyst subunit
(Sec6), carefully mapped epitopes bound by more than 20
distinct mAbs and used them to probe subdomain accessibility
in exocyst complexes associated with different cellular
compartments.
A major finding of this work is that epitopes mapping to
different segments of Sec6 are exposed or concealed in a spatially
controlled fashion in epithelial cells. Sec6 is an obligate binding
partner of Sec8, and is entirely associated with largemulti-protein
assemblies in MDCK cells. Nevertheless, anti-Sec6 mAbs detect
epitopes on different parts of this protein at different subcellular
localizations. Of equal importance, no single epitope is exposed at
all of these sites. This suggests that the majority of Sec6 epitopes
are concealed at most sites, and that only a small subset of
epitopes are exposed and this occurs in a site-specific manner.
Therefore, Sec6 epitopes and the mAbs that bind them define
exocyst complexes associated with one, or a small subset of
cellular compartments, where they are presumably engaged in
only one activity.
We also note that discrete Sec6 epitopesmay appear, disappear
or redistribute as cells grow and differentiate. For example,
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antibodies to the NT1 domain label centrosomes, but only
when cells are undergoing mitosis. In contrast, antibodies to
the NT2 domain label nucleoli of interphase cells, but do not
detect Sec6 anywhere in mitotic cells. Epitopes in the C-terminal
domain appear to redistribute during epithelial cell polarity
development. The CT2b segment is accessible for mAb 11A2
binding to a pool of Sec6 associated with vimentin filaments
in non-polarized cells, and no plasma membrane labeling with
this antibody is observed under these conditions. However, the
same antibody reveals Sec6 associated with apical and basolateral
domains of fully polarized cells. Similarly, the CT3 segment is
accessible for mAb 8A5 binding to a pool of Sec6 associated
with desmosomes in non-polarized cells and 2-D polarized cells
on Transwells (Andersen and Yeaman, 2010). However, this
antibody labels Sec6 in a continuous and uniform distribution
along the basolateral plasma membrane of fully polarized cells
grown in Matrigel. Antibodies to the CT1 domain detect Sec6
at newly forming adhesive junctions and mark a complex that
becomes restricted to the AJC in polarized cells grown on
Transwell filters (Grindstaff et al., 1998; Yeaman et al., 2004),
but do not specifically label Sec6 in fully polarized 3-D cysts.
We acknowledge that care must be taken to distinguish between
physical redistribution of exocyst complexes and changes in
conformation and/or molecular associations that reveal or
conceal epitopes at a given site, because both are likely to
accompany epithelial polarity development. Because gentle pre-
extraction with non-ionic detergent exposes Sec6 CT1 epitopes at
the AJC of MDCK cysts, we conclude that either intramolecular
interactions within the exocyst holocomplex or associations with
accessory proteins mask these epitopes in fully polarized cells.
Such molecular rearrangements are likely to be regulated, at
least in part, by RalA, because suppressing expression of this
GTPase significantly diminished binding of CT1-specific mAbs
to plasma membranes without affecting the expression, assembly
or recruitment of exocyst complexes to this site.
We anticipate that a thorough analysis of epitope accessibility
of each subunit will reveal important details about exocyst
structure, function and regulation during its involvement in
many different cellular processes. A complete understanding
of these functions will require comprehensive identification of
accessory proteins with which exocyst holocomplexes interact at
different sites. We have shown that Sec6 epitopes, and the mAbs
that bind them, define exocyst complexes associated with one (or
a small subset of) cellular compartments. As such, the library of
Sec6 mAbs is likely to be an important resource for the study
of different cohorts of exocyst complexes engaged in different
cellular processes.
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